Sera Prognostics Inc
Sera Prognostics Inc (SERA) Covered Calls
As of September 17, 2026, SERA has 1 covered call opportunities in the coming three months. Return ranges from 25.6 to 25.6% until expiration. Annualized return ranges from 60.3 to 60.3%. The nearest expiration is February 19, 2027. Maximum potential profit is $53.
Read more
Running SERA covered calls helps you generate consistent income from Sera Prognostics Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Sera Prognostics Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best SERA covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if SERA stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling SERA covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Sera Prognostics Inc covered call is worth writing.
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
Income-focused investors, long-term SERA holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling SERA covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Sera Prognostics Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryMedical Devices
- SectorHealthcare
- IV percentile61.51% Neutral
- Market cap (M$)82
- 52 weeks high-47.59%
- 52 weeks low32.69%
- Analyst recommendationStrong Buy
1.00 - Target price$5.50
160.66% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-12
- P/E—
- Future P/E—
- EPS (ttm)-0.66
- EPS growth next 5 years9.06%
As of September 17, 2026
| 2027-02-19 | 155 | 2.50 | 20.77 | 0.10 | 0.95 | 53.00 | 25.60 | 60.29 | -4.83 | +0.57 | 6 | 0.85 |
As of September 17, 2026
Sell covered calls with the data behind you
Find the best SERA covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→